Madrigal Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$430.07(as of Oct 21, 3:59 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Madrigal Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$430.07
Ticker SymbolMDGL
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees528
CountyUSA
Market Cap$9,782.6M
EBIDTA-308.4M
10-Day Moving Average435.04
P/E Ratio-34.66
20-Day Moving Average437.68
Forward P/E Ratio0.00
50-Day Moving Average424.58
Earnings per Share-12.64
200-Day Moving Average341.00
Profit Margin-19.87%
RSI54.94
Shares Outstanding22.3M
ATR16.95
52-Week High463.63
Volume278,980
52-Week Low200.63
Book Value696.0M
P/B Ratio14.04
Upper Keltner475.81
P/S Ratio18.95
Lower Keltner399.55
Debt-to-Equity Ratio475.81
Next Earnings Date10/29/2025
Cash Surplus-5.3M
Next Ex-Dividend DateUnknown
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.
Madrigal Pharmaceuticals Inc In Our Stock Scanner
As of Oct 21, 2025
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Scan Name: Hammer CandleScan Type: Candlestick Pattern Scans
As of ---
Scan Name: Dragonfly DojiScan Type: Candlestick Pattern Scans
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Doji CandlesScan Type: Candlestick Pattern Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.